Skip to main content
. 2021 Jun 8;9(6):620. doi: 10.3390/vaccines9060620

Figure 1.

Figure 1

Analysis of yeast-produced VHHs by reducing SDS-PAGE. VHHs M651F and M655F, which contain potential N-glycosylation sites, were treated with endoglycosidase H (endoH). VHHs were analyzed on two gels (panels (a,b)) and are arranged according to their CDR3 group. A single lane left of M661F was removed from panel a. Newly isolated VHHs of the same CDR3 group are indicated using the same color. The position of N-glycosylated M655F and degradation products of VHHs are indicated at the right. The molecular weight of markers used is indicated.